Friday, Apr 12, 2024 | Last Update : 10:32 PM IST

  India   All India  14 Dec 2021  NTAGI analyzes data of Covid infections in India to decide on booster dose

NTAGI analyzes data of Covid infections in India to decide on booster dose

ANI
Published : Dec 14, 2021, 2:13 pm IST
Updated : Dec 14, 2021, 2:13 pm IST

During its last meeting, the NTAGI had made no final recommendation on additional COVID-19 vaccine doses

A health worker administers a dose of COVID-19 vaccine to a beneficiary at K R Market, amid possible threat for spread of Omicron variant of COVID-19, in Bengaluru. (Photo: PTI/File)
 A health worker administers a dose of COVID-19 vaccine to a beneficiary at K R Market, amid possible threat for spread of Omicron variant of COVID-19, in Bengaluru. (Photo: PTI/File)

New Delhi: To make a decision regarding a booster dose of the COVID-19 vaccine, the National Technical Advisory Group on Immunisation (NTAGI) is analyzing data of COVID-19 breakthrough infections in India, said sources on Tuesday.

As per the sources, "NTAGI is analyzing data of COVID-19 breakthrough infections in India, to look at the vaccine effectiveness and take a decision regarding additional and booster dose."

During its last meeting, the NTAGI had made no final recommendation on additional COVID-19 vaccine doses and vaccines for children. However, both the issues were discussed in the meeting and the booster dose was not on the agenda of today's meeting.

Tags: national technical advisory group on immunisation
Location: India, Delhi, New Delhi